MED Medifast PE ratio, current and historical analysis
The current PE ratio for Medifast stock as of Mar 21, 2025 is 75.47. This is calculated based on the TTM EPS of $0.19 and the stock price of $14.34 per share. The PE ratio has grown by 122% from its last 4 quarters average of 34.0.
MED PE ratio history
The average historical PE ratio of Medifast for the last ten years is 22.53. The current price-to-earnings ratio of 75.47 is in line with the historical average. Analyzing the last ten years, MED's PE ratio reached its highest point in the Dec 2024 quarter at 92.74, when the price was $17.62 and the EPS was $0.19. The lowest point was recorded in the Mar 2024 quarter, when it reached 6.17 with a price of $38.32 and an EPS of $6.21.
Medifast PE ratio by year
Maximum annual increase: 1,160.05% in 2024
Maximum annual decrease: -50.34% in 2011
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 92.74 | 1,160.05% | $17.62 | $0.19 |
| 2023 | 7.36 | -18.22% | $67.22 | $9.13 |
| 2022 | 9 | -39.8% | $115.35 | $12.82 |
| 2021 | 14.95 | -33.44% | $209.43 | $14.01 |
| 2020 | 22.46 | 35.71% | $196.34 | $8.74 |
| 2019 | 16.55 | -38.18% | $109.58 | $6.62 |
| 2018 | 26.77 | -11.03% | $125.02 | $4.67 |
| 2017 | 30.09 | 9.14% | $69.81 | $2.32 |
| 2016 | 27.57 | 52.49% | $41.63 | $1.51 |
| 2015 | 18.08 | -43.96% | $30.38 | $1.68 |
| 2014 | 32.26 | 114.78% | $33.55 | $1.04 |
| 2013 | 15.02 | -33.98% | $26.13 | $1.74 |
| 2012 | 22.75 | 120.45% | $26.39 | $1.16 |
| 2011 | 10.32 | -50.34% | $13.72 | $1.33 |
| 2010 | 20.78 | -42.91% | $28.88 | $1.39 |
Medifast PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 92.74 | 219.79% | $17.62 | $0.19 |
| Sep 2024 | 29 | 256.27% | $19.14 | $0.66 |
| Jun 2024 | 8.14 | 31.93% | $21.82 | $2.68 |
| Mar 2024 | 6.17 | -16.17% | $38.32 | $6.21 |
| Dec 2023 | 7.36 | 8.39% | $67.22 | $9.13 |
| Sep 2023 | 6.79 | -10.07% | $74.85 | $11.03 |
| Jun 2023 | 7.55 | -6.33% | $92.16 | $12.21 |
| Mar 2023 | 8.06 | -10.44% | $103.67 | $12.87 |
| Dec 2022 | 9 | 10.43% | $115.35 | $12.82 |
| Sep 2022 | 8.15 | -38.63% | $108.36 | $13.3 |
| Jun 2022 | 13.28 | 10.02% | $180.51 | $13.59 |
| Mar 2022 | 12.07 | -19.26% | $170.78 | $14.15 |
| Dec 2021 | 14.95 | 4.47% | $209.43 | $14.01 |
| Sep 2021 | 14.31 | -35.28% | $192.64 | $13.46 |
| Jun 2021 | 22.11 | 11.27% | $282.98 | $12.8 |
MED average PE ratio chart
Currently, MED's PE ratio is above its 3, 5 and 10-year averages.
MED PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| MED Medifast Inc | 75.47 | $156.85M |
| WTW Willis Towers Watson Plc | N/A | $33.17B |
| ABEO Abeona Therapeutics Inc | N/A | $249.95M |
Frequently asked questions
What is Medifast's PE ratio?
As of Mar 21, 2025, MED stock has a price to earnings ratio of 75.47.
What is the 3-year average PE ratio for Medifast (MED)?
Over the last 3 years, the average PE ratio for MED stock is 17.36.
What is the 5-year average PE ratio for Medifast (MED)?
Over the last 5 years, the average PE ratio for MED stock is 17.67.
What is the highest PE ratio for MED?
Over the last ten years, the quarterly PE ratio reached its highest level at 92.74 in the Dec 2024 quarter.
How does the current PE ratio for MED compare to its historical average?
The current PE ratio of MED is 235% higher than the 10-year historical average.
Why is Medifast's PE ratio so high?
MED's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
How is MED's PE ratio calculated (Medifast PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Mar 21, 2025), Medifast's share price is $14.34. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.19. Therefore, Medifast's price to earnings ratio for today is 75.47. PE RATIO(75.47) = STOCK PRICE($14.34) / TTM EPS($0.19)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.